The Arkansas Highway Police (AHP) made "two significant drug busts" during recent commercial vehicle traffic stops along I-40 ...
California prescription drug transparency efforts face new scrutiny over pharmaceutical marketing, patient advocacy funding, PBM pricing practices and insulin costs.
Tropical forests hold up to $714 billion in potential drug value, with the Amazon accounting for $215 billion of the total, ...
The Kerala High Court on Monday (September 28) held that Section 100 of the Patents Act can be invoked by the Central ...
GlobalData on MSN
Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians
The collaboration pairs Firefly's AI-powered brain-assessment platform with NeuroSigma's FDA-cleared, non-medication device ...
In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...
NDA submission completed following positive Phase 3 SELVA results; potential U.S. commercial launch in the first half of 2027 ...
BIIB's growth products now outpace its legacy MS portfolio, with Skyclarys, Zurzuvae and newer drugs driving a shift in revenue mix.
Marijuana rescheduling is underway, but DOT drug testing remains in place. Here’s what employers should know about medical marijuana, MRO review and FMCSA rules.
Merck said on Monday it would pay ​up to $2.13 billion under a global licensing deal with China's SciBrunch Therapeutics for ...
Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...
Merck (MRK) acquires worldwide rights to SPR2015 cancer drug from SciBrunch in deal valued at $2.13B, targeting common KRAS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results